Deep Responses in Multiple Myeloma Seen With Bispecific Antibody
Jeffrey Zonder, MD, discusses the efficacy results of a first-in-human trial of a bispecific monoclonal antibody in patients with relapsed/refractory multiple myeloma.
New Bispecific Antibody Shows Favorable Tolerability in Multiple Myeloma
Jeffrey Zonder, MD, discusses the safety results of a first-in-human trial of a bispecific monoclonal antibody in patients with relapsed/refractory multiple myeloma.